Skip to content

Clinical observation of acupuncture in the treatment of chronic prostatitis

Clinical observation of acupuncture in the treatment of chronic prostatitis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006067
Enrollment
Unknown
Registered
2022-06-05
Start date
2022-05-23
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic prostatitis

Interventions

test group:Acupuncture at Guanyuan and Zhongji
control group:Acupuncture in Zhongliao, Huiyang

Sponsors

Dongzhimen Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria for type III chronic prostatitis; (2) Age 18-50; (3) The course of the disease is more than 3 months; (4) NIH-CPSI score = 15 points; (5) Voluntarily cooperate with acupuncture treatment and sign the informed consent. Only if the above five items are met at the same time can be included.

Exclusion criteria

Exclusion criteria: (1) Combined with other urinary system-related diseases, such as: other types of prostatitis, prostate tumors, urinary tract infections, bladder outlet obstruction, cystitis, bladder tumors, etc.; (2) Combination of diseases affecting the function of the lower urinary tract, such as: multiple sclerosis, Parkinson's disease, spinal cord injury, cauda equina injury, stroke and multiple system atrophy; (3) Taking drugs to relieve symptoms of CP/CPPS in the past 2 months, or receiving non-drug therapy; (4) Complicated with severe cardiovascular disease, cerebrovascular disease, liver and kidney insufficiency, blood system disease, and mental disease; (5) There are any contraindications to acupuncture, scars or infections at the site of acupuncture, or systemic diseases that researchers believe are inappropriate for measures; (6) Those who are participating in other clinical trials. Those who meet any of the above items are not eligible to join the group.

Design outcomes

Primary

MeasureTime frame
National Institutes of Health chronic prostatitis symptom index;

Secondary

MeasureTime frame
International Prostate Symptom Score;

Countries

China

Contacts

Public ContactJiping Zhao
zjp7883@sina.com13621382136

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026